Acadia Healthcare stock hits 52-week low at $20.31

Acadia Healthcare (NASDAQ:ACHC) Company Inc’s stock reached a new 52-week low, closing at $20.31. According to InvestingPro analysis, the company appears undervalued at current levels, with analysts setting price targets ranging from $27 to $66. This milestone reflects a significant downturn for the company, which has seen its stock price decline by 69.34% over the past year. While the healthcare provider operates with a significant debt burden, InvestingPro data shows the company remains profitable with a P/E ratio of 10.87. The healthcare provider has faced various challenges that have contributed to this downward trend, impacting investor confidence and market performance. The new low underscores the company’s ongoing struggles in a competitive and evolving healthcare landscape. Despite these challenges, InvestingPro subscribers can access detailed analysis including 6 additional ProTips and a comprehensive Pro Research Report, offering deeper insights into the company’s financial health and future prospects.

In other recent news, Acadia Healthcare Company, Inc. reported second-quarter earnings that exceeded analyst expectations. The company announced adjusted earnings of $0.83 per share, surpassing the projected $0.70 per share. Revenue for the quarter reached $869.2 million, exceeding the consensus estimate of $840.42 million and marking a 9.2% increase compared to the same period last year. Despite these positive earnings results, Acadia Healthcare’s full-year guidance midpoint fell below consensus estimates. Additionally, the company announced the departure of its Chief Financial Officer, which coincided with a 3.5% drop in share value. These developments are part of the company’s recent announcements.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.